Related Experiment Videos
Apoptotic markers for tumor recurrence: a minireview
A-E Konstantinidou1, P Korkolopoulou, E Patsouris
1Department of Pathology, Faculty of Medicine, National University of Athens, Greece. takonst@hol.gr
Apoptosis : an International Journal on Programmed Cell Death
|September 11, 2002
Summary
Apoptosis control is key in tumor biology and recurrence. While markers like bcl-2 and p53 show promise, predicting tumor recurrence requires complex models combining molecular data with traditional factors.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Apoptosis is crucial for preventing tumor development and is a target for cancer therapies.
- Resistance to apoptosis can drive tumor evolution and treatment failure.
- Apoptotic mechanisms are implicated in cancer recurrence.
Purpose of the Study:
- To review the predictive value of apoptotic markers for tumor recurrence.
- To highlight the limitations of single markers and the need for integrated predictive models.
Main Methods:
- Review of current evidence on apoptotic markers (e.g., bcl-2, p53) and apoptotic rate.
- Analysis of retrospective studies and identification of limitations.
Main Results:
- bcl-2, p53, and apoptotic rate show prognostic potential in some cancers.
- Current evidence is largely from single-center retrospective studies requiring validation.
- Individual molecular markers are insufficient for predicting clinical outcomes.
Conclusions:
- Predicting tumor recurrence is complex and requires integrated models combining molecular biomarkers with traditional prognostic factors.
- Such models can aid in defining prognostic categories and guiding treatment decisions.